Company History
July 2006
PeptiDream was founded in Tokyo, Japan
December 2006
Entered into a sub-licensable exclusive license agreement with the University of Tokyo on
Flexizyme Technology
May 2007
Entered into a sub-licensable exclusive license agreement with the State University of
New York on Flexizyme Technology
March 2009
Relocated corporate headquarters to RCAST (Research Center for Advanced Science and
Technology, The University of Tokyo)
April 2010
Relocated corporate headquarters and research laboratories to Komaba Reserch Campus, The
University of Tokyo
October 2010
Established its proprietary technology “Peptide Discovery Platform System (PDPS).”
June 2013
Listed on the Tokyo Stock Exchange Mothers
December 2015
Listed on the first section of the Tokyo Stock Exchange.
July 2017
Relocated corporate headquarters to Tonomachi, Kawasaki City.
September 2017
Patrick C. Reid was appointed as President and CEO
September 2017
PeptiStar Inc. was founded through a joint venture agreement between PeptiDream Inc.,
Shionogi & Co., Ltd. and Sekisui Chemical Co., Ltd.
April 2020
PeptiGrowth Inc. was founded through a joint venture agreement between PeptiDream Inc.
and Mitsubishi Corporation.
November 2020
PeptiAID Inc. was founded through a joint venture agreement between PeptiDream Inc.,
Fujitsu Limited, Mizuho Capital
Co., Ltd., Takenaka Corporation and KISHIDA CHEMICAL CO., LTD.
March 2022
Fully acquire a newly established company, PDRadiopharma Inc. that succeeds the
radiopharmaceutical business of Fujifilm
Toyama Chemical.
April 2022
Changed to the Prime Market of the Tokyo Stock Exchange
